CRISPR-Cas9 Gene Editing of the Sal1 Gene Family in Wheat

被引:12
|
作者
Mohr, Toni [1 ]
Horstman, James [1 ]
Gu, Yong Q. [1 ]
Elarabi, Nagwa I. [2 ]
Abdallah, Naglaa A. [2 ]
Thilmony, Roger [1 ]
机构
[1] ARS, USDA, Crop Improvement & Genet Unit, Albany, CA 94710 USA
[2] Cairo Univ, Fac Agr, Dept Genet, Giza 12613, Egypt
来源
PLANTS-BASEL | 2022年 / 11卷 / 17期
关键词
CRISPR; wheat; Sal1; drought tolerance; Triticum aestivum; gene editing; TARGETED MUTAGENESIS; ARABIDOPSIS; DROUGHT; EXPRESSION; RNA; TOLERANCE; STRESS;
D O I
10.3390/plants11172259
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The highly conserved Sal1 encodes a bifunctional enzyme with inositol polyphosphate-1-phosphatase and 3' (2'), 5'-bisphosphate nucleotidase activity and has been shown to alter abiotic stress tolerance in plants when disrupted. Precise gene editing techniques were used to generate Sal1 mutants in hexaploid bread wheat. The CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats) Cas9 system with three guide RNAs (gRNAs) was used to inactivate six Sal1 homologous genes within the Bobwhite wheat genome. The resulting mutant wheat plants with all their Sal1 genes disabled had slimmer stems, had a modest reduction in biomass and senesced more slowly in water limiting conditions, but did not exhibit improved yield under drought conditions. Our results show that multiplexed gRNAs enabled effective targeted gene editing of the Sal1 gene family in hexaploid wheat. These Sal1 mutant wheat plants will be a resource for further research studying the function of this gene family in wheat.
引用
下载
收藏
页数:16
相关论文
共 50 条
  • [1] Controlling CRISPR-Cas9 Gene Editing
    Dowdy, Steven F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
  • [2] Introduction to CRISPR-Cas9 Gene Editing
    Mason, J. M.
    BIRTH DEFECTS RESEARCH, 2020, 112 (11): : 809 - 809
  • [3] Gene Editing of Human Hepatocytes by CRISPR-Cas9
    Zhang, Qingshuo
    Tiyaboonchai, Amita
    Balaji, Niveditha
    Naugler, Willscott
    Grompe, Markus
    MOLECULAR THERAPY, 2018, 26 (05) : 367 - 367
  • [4] CRISPR-cas9 Gene Editing for Cystic Fibrosis
    Xia, Emily
    MOLECULAR THERAPY, 2019, 27 (04) : 196 - 196
  • [5] CRISPR-Cas9 gene editing and human diseases
    Jinka, Chaitra
    Sainath, Chithirala
    Babu, Shyamaladevi
    Chakravarthi, Chennupati Ashok
    Prasanna, Muppidi Lakshmi
    Krishnan, Madhan
    Sekar, Gayathri
    Chinnaiyan, Mayilvanan
    Kumari, Andugula Swapna
    BIOINFORMATION, 2022, 18 (11) : 1081 - 1086
  • [6] CRISPR-Cas9 gene editing for patients with haemoglobinopathies
    不详
    LANCET HAEMATOLOGY, 2019, 6 (09): : E438 - E438
  • [7] Transgenerational CRISPR-Cas9 Activity Facilitates Multiplex Gene Editing in Allopolyploid Wheat
    Wang, Wei
    Pan, Qianli
    He, Fei
    Akhunova, Alina
    Chao, Shiaoman
    Trick, Harold
    Akhunov, Eduard
    CRISPR JOURNAL, 2018, 1 (01): : 65 - 74
  • [8] Application of CRISPR-Cas9 gene editing to treat HBV
    Yan, Kun
    Feng, Jiangpeng
    Xiong, Yong
    Chen, Yu
    CHINESE SCIENCE BULLETIN-CHINESE, 2019, 64 (30): : 3142 - 3150
  • [9] CRISPR-cas9 gene editing in undergraduate laboratory experience
    Kee, H. Lynn
    Pieczynski, Jay
    FASEB JOURNAL, 2019, 33
  • [10] Gene editing for the treatment of lung cancer (CRISPR-Cas9)
    Castillo, Andres
    COLOMBIA MEDICA, 2016, 47 (04): : 178 - 180